ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

Precision Targeting with EZH2 and HDAC Inhibitors in Epigenetically Dysregulated Lymphomas.

Jennifer K Lue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.